Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the research report published by Market IntelliX, the global market for Sterile Formulation Development should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Sterile Formulation Development market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Sterile Formulation Development market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Liquid Dosage Form segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Preclinical has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Sterile Formulation Development include Dalton Pharma Services, PCI Pharma Services, Bioprocess Online, Farbe Firma, Anglo Bio-Pharma Limited, Thermo Fisher Scientific, Pfizer CentreOne, Piramal Pharma Solutions and Ardena, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Sterile Formulation Development. Report Highlights:
(1) Global Sterile Formulation Development market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Sterile Formulation Development market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Sterile Formulation Development market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Sterile Formulation Development segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Sterile Formulation Development segment by type and by application and regional segment by type and by application.
(6) Sterile Formulation Development industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Liquid Dosage Form
Lyophilized Dosage Form
Frozen Dosage Form
Others
Market segment by application, can be divided into
Preclinical
Clinical
Commercial
Market segment by players, this report covers
Dalton Pharma Services
PCI Pharma Services
Bioprocess Online
Farbe Firma
Anglo Bio-Pharma Limited
Thermo Fisher Scientific
Pfizer CentreOne
Piramal Pharma Solutions
Ardena
Curida
Curia Global
Carbogen Amcis
Woodstock Sterile Solutions
Cambrex
Aenova Group
Lonza
Catalent
PPD
Althea
Baxter
1 Market Overview
1.1 Product Overview and Scope of Sterile Formulation Development
1.2 Global Sterile Formulation Development Market Size and Forecast
1.3 China Sterile Formulation Development Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Sterile Formulation Development Share in Global Market, 2018-2029
1.4.2 Sterile Formulation Development Market Size: China VS Global, 2018-2029
1.5 Sterile Formulation Development Market Dynamics
1.5.1 Sterile Formulation Development Market Drivers
1.5.2 Sterile Formulation Development Market Restraints
1.5.3 Sterile Formulation Development Industry Trends
1.5.4 Sterile Formulation Development Industry Policy
2 Global Competitive Situation by Company
2.1 Global Sterile Formulation Development Revenue by Company (2018-2023)
2.2 Global Sterile Formulation Development Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Sterile Formulation Development Concentration Ratio
2.4 Global Sterile Formulation Development Mergers & Acquisitions, Expansion Plans
2.5 Global Sterile Formulation Development Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Sterile Formulation Development Revenue by Company (2018-2023)
3.2 China Sterile Formulation Development Sterile Formulation Development Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Sterile Formulation Development, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Sterile Formulation Development Industry Chain
4.2 Sterile Formulation Development Upstream Analysis
4.3 Sterile Formulation Development Midstream Analysis
4.4 Sterile Formulation Development Downstream Analysis
5 Sights by Type
5.1 Sterile Formulation Development Classification
5.1.1 Liquid Dosage Form
5.1.2 Lyophilized Dosage Form
5.1.3 Frozen Dosage Form
5.1.4 Others
5.2 By Type, Global Sterile Formulation Development Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Sterile Formulation Development Revenue, 2018-2029
6 Sights by Application
6.1 Sterile Formulation Development Segment by Application
6.1.1 Preclinical
6.1.2 Clinical
6.1.3 Commercial
6.2 By Application, Global Sterile Formulation Development Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Sterile Formulation Development Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Sterile Formulation Development Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Sterile Formulation Development Market Size, 2018-2029
7.3 North America
7.3.1 North America Sterile Formulation Development Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Sterile Formulation Development Market Size Market Share
7.4 Europe
7.4.1 Europe Sterile Formulation Development Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Sterile Formulation Development Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Sterile Formulation Development Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Sterile Formulation Development Market Size Market Share
7.6 South America
7.6.1 South America Sterile Formulation Development Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Sterile Formulation Development Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Sterile Formulation Development Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Sterile Formulation Development Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Sterile Formulation Development Market Size, 2018-2029
8.3.2 By Company, U.S. Sterile Formulation Development Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Sterile Formulation Development Market Size, 2018-2029
8.4.2 By Company, Europe Sterile Formulation Development Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Sterile Formulation Development Market Size, 2018-2029
8.5.2 By Company, China Sterile Formulation Development Revenue Market Share, 2018-2023
8.5.3 By Type, China Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Sterile Formulation Development Market Size, 2018-2029
8.6.2 By Company, Japan Sterile Formulation Development Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Sterile Formulation Development Market Size, 2018-2029
8.7.2 By Company, South Korea Sterile Formulation Development Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Sterile Formulation Development Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Sterile Formulation Development Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Sterile Formulation Development Market Size, 2018-2029
8.9.2 By Company, India Sterile Formulation Development Revenue Market Share, 2018-2023
8.9.3 By Type, India Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Sterile Formulation Development Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Sterile Formulation Development Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Sterile Formulation Development Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Sterile Formulation Development Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Dalton Pharma Services
9.1.1 Dalton Pharma Services Company Information, Head Office, Market Area and Industry Position
9.1.2 Dalton Pharma Services Company Profile and Main Business
9.1.3 Dalton Pharma Services Sterile Formulation Development Models, Specifications and Application
9.1.4 Dalton Pharma Services Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.1.5 Dalton Pharma Services Recent Developments
9.2 PCI Pharma Services
9.2.1 PCI Pharma Services Company Information, Head Office, Market Area and Industry Position
9.2.2 PCI Pharma Services Company Profile and Main Business
9.2.3 PCI Pharma Services Sterile Formulation Development Models, Specifications and Application
9.2.4 PCI Pharma Services Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.2.5 PCI Pharma Services Recent Developments
9.3 Bioprocess Online
9.3.1 Bioprocess Online Company Information, Head Office, Market Area and Industry Position
9.3.2 Bioprocess Online Company Profile and Main Business
9.3.3 Bioprocess Online Sterile Formulation Development Models, Specifications and Application
9.3.4 Bioprocess Online Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.3.5 Bioprocess Online Recent Developments
9.4 Farbe Firma
9.4.1 Farbe Firma Company Information, Head Office, Market Area and Industry Position
9.4.2 Farbe Firma Company Profile and Main Business
9.4.3 Farbe Firma Sterile Formulation Development Models, Specifications and Application
9.4.4 Farbe Firma Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.4.5 Farbe Firma Recent Developments
9.5 Anglo Bio-Pharma Limited
9.5.1 Anglo Bio-Pharma Limited Company Information, Head Office, Market Area and Industry Position
9.5.2 Anglo Bio-Pharma Limited Company Profile and Main Business
9.5.3 Anglo Bio-Pharma Limited Sterile Formulation Development Models, Specifications and Application
9.5.4 Anglo Bio-Pharma Limited Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.5.5 Anglo Bio-Pharma Limited Recent Developments
9.6 Thermo Fisher Scientific
9.6.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.6.2 Thermo Fisher Scientific Company Profile and Main Business
9.6.3 Thermo Fisher Scientific Sterile Formulation Development Models, Specifications and Application
9.6.4 Thermo Fisher Scientific Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.6.5 Thermo Fisher Scientific Recent Developments
9.7 Pfizer CentreOne
9.7.1 Pfizer CentreOne Company Information, Head Office, Market Area and Industry Position
9.7.2 Pfizer CentreOne Company Profile and Main Business
9.7.3 Pfizer CentreOne Sterile Formulation Development Models, Specifications and Application
9.7.4 Pfizer CentreOne Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.7.5 Pfizer CentreOne Recent Developments
9.8 Piramal Pharma Solutions
9.8.1 Piramal Pharma Solutions Company Information, Head Office, Market Area and Industry Position
9.8.2 Piramal Pharma Solutions Company Profile and Main Business
9.8.3 Piramal Pharma Solutions Sterile Formulation Development Models, Specifications and Application
9.8.4 Piramal Pharma Solutions Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.8.5 Piramal Pharma Solutions Recent Developments
9.9 Ardena
9.9.1 Ardena Company Information, Head Office, Market Area and Industry Position
9.9.2 Ardena Company Profile and Main Business
9.9.3 Ardena Sterile Formulation Development Models, Specifications and Application
9.9.4 Ardena Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.9.5 Ardena Recent Developments
9.10 Curida
9.10.1 Curida Company Information, Head Office, Market Area and Industry Position
9.10.2 Curida Company Profile and Main Business
9.10.3 Curida Sterile Formulation Development Models, Specifications and Application
9.10.4 Curida Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.10.5 Curida Recent Developments
9.11 Curia Global
9.11.1 Curia Global Company Information, Head Office, Market Area and Industry Position
9.11.2 Curia Global Company Profile and Main Business
9.11.3 Curia Global Sterile Formulation Development Models, Specifications and Application
9.11.4 Curia Global Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.11.5 Curia Global Recent Developments
9.12 Carbogen Amcis
9.12.1 Carbogen Amcis Company Information, Head Office, Market Area and Industry Position
9.12.2 Carbogen Amcis Company Profile and Main Business
9.12.3 Carbogen Amcis Sterile Formulation Development Models, Specifications and Application
9.12.4 Carbogen Amcis Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.12.5 Carbogen Amcis Recent Developments
9.13 Woodstock Sterile Solutions
9.13.1 Woodstock Sterile Solutions Company Information, Head Office, Market Area and Industry Position
9.13.2 Woodstock Sterile Solutions Company Profile and Main Business
9.13.3 Woodstock Sterile Solutions Sterile Formulation Development Models, Specifications and Application
9.13.4 Woodstock Sterile Solutions Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.13.5 Woodstock Sterile Solutions Recent Developments
9.14 Cambrex
9.14.1 Cambrex Company Information, Head Office, Market Area and Industry Position
9.14.2 Cambrex Company Profile and Main Business
9.14.3 Cambrex Sterile Formulation Development Models, Specifications and Application
9.14.4 Cambrex Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.14.5 Cambrex Recent Developments
9.15 Aenova Group
9.15.1 Aenova Group Company Information, Head Office, Market Area and Industry Position
9.15.2 Aenova Group Company Profile and Main Business
9.15.3 Aenova Group Sterile Formulation Development Models, Specifications and Application
9.15.4 Aenova Group Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.15.5 Aenova Group Recent Developments
9.16 Lonza
9.16.1 Lonza Company Information, Head Office, Market Area and Industry Position
9.16.2 Lonza Company Profile and Main Business
9.16.3 Lonza Sterile Formulation Development Models, Specifications and Application
9.16.4 Lonza Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.16.5 Lonza Recent Developments
9.17 Catalent
9.17.1 Catalent Company Information, Head Office, Market Area and Industry Position
9.17.2 Catalent Company Profile and Main Business
9.17.3 Catalent Sterile Formulation Development Models, Specifications and Application
9.17.4 Catalent Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.17.5 Catalent Recent Developments
9.18 PPD
9.18.1 PPD Company Information, Head Office, Market Area and Industry Position
9.18.2 PPD Company Profile and Main Business
9.18.3 PPD Sterile Formulation Development Models, Specifications and Application
9.18.4 PPD Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.18.5 PPD Recent Developments
9.19 Althea
9.19.1 Althea Company Information, Head Office, Market Area and Industry Position
9.19.2 Althea Company Profile and Main Business
9.19.3 Althea Sterile Formulation Development Models, Specifications and Application
9.19.4 Althea Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.19.5 Althea Recent Developments
9.20 Baxter
9.20.1 Baxter Company Information, Head Office, Market Area and Industry Position
9.20.2 Baxter Company Profile and Main Business
9.20.3 Baxter Sterile Formulation Development Models, Specifications and Application
9.20.4 Baxter Sterile Formulation Development Revenue and Gross Margin, 2018-2023
9.20.5 Baxter Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Sterile Formulation Development Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Sterile Formulation Development Market Restraints
Table 3. Sterile Formulation Development Market Trends
Table 4. Sterile Formulation Development Industry Policy
Table 5. Global Sterile Formulation Development Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Sterile Formulation Development Revenue Market Share by Company (2018-2023)
Table 7. Global Sterile Formulation Development Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Sterile Formulation Development Mergers & Acquisitions, Expansion Plans
Table 9. Global Sterile Formulation Development Manufacturers Product Type
Table 10. China Sterile Formulation Development Revenue by Company (2018-2023) & (US$ million)
Table 11. China Sterile Formulation Development Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Sterile Formulation Development Upstream (Raw Materials)
Table 13. Global Sterile Formulation Development Typical Customers
Table 14. Sterile Formulation Development Typical Distributors
Table 15. By Type, Global Sterile Formulation Development Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Sterile Formulation Development Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Sterile Formulation Development Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Sterile Formulation Development Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Sterile Formulation Development Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Sterile Formulation Development Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Sterile Formulation Development Revenue Market Share, 2018-2029
Table 22. Dalton Pharma Services Company Information, Head Office, Market Area and Industry Position
Table 23. Dalton Pharma Services Company Profile and Main Business
Table 24. Dalton Pharma Services Sterile Formulation Development Models, Specifications and Application
Table 25. Dalton Pharma Services Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 26. Dalton Pharma Services Recent Developments
Table 27. PCI Pharma Services Company Information, Head Office, Market Area and Industry Position
Table 28. PCI Pharma Services Company Profile and Main Business
Table 29. PCI Pharma Services Sterile Formulation Development Models, Specifications and Application
Table 30. PCI Pharma Services Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 31. PCI Pharma Services Recent Developments
Table 32. Bioprocess Online Company Information, Head Office, Market Area and Industry Position
Table 33. Bioprocess Online Company Profile and Main Business
Table 34. Bioprocess Online Sterile Formulation Development Models, Specifications and Application
Table 35. Bioprocess Online Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 36. Bioprocess Online Recent Developments
Table 37. Farbe Firma Company Information, Head Office, Market Area and Industry Position
Table 38. Farbe Firma Company Profile and Main Business
Table 39. Farbe Firma Sterile Formulation Development Models, Specifications and Application
Table 40. Farbe Firma Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 41. Farbe Firma Recent Developments
Table 42. Anglo Bio-Pharma Limited Company Information, Head Office, Market Area and Industry Position
Table 43. Anglo Bio-Pharma Limited Company Profile and Main Business
Table 44. Anglo Bio-Pharma Limited Sterile Formulation Development Models, Specifications and Application
Table 45. Anglo Bio-Pharma Limited Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 46. Anglo Bio-Pharma Limited Recent Developments
Table 47. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 48. Thermo Fisher Scientific Company Profile and Main Business
Table 49. Thermo Fisher Scientific Sterile Formulation Development Models, Specifications and Application
Table 50. Thermo Fisher Scientific Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 51. Thermo Fisher Scientific Recent Developments
Table 52. Pfizer CentreOne Company Information, Head Office, Market Area and Industry Position
Table 53. Pfizer CentreOne Company Profile and Main Business
Table 54. Pfizer CentreOne Sterile Formulation Development Models, Specifications and Application
Table 55. Pfizer CentreOne Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 56. Pfizer CentreOne Recent Developments
Table 57. Piramal Pharma Solutions Company Information, Head Office, Market Area and Industry Position
Table 58. Piramal Pharma Solutions Company Profile and Main Business
Table 59. Piramal Pharma Solutions Sterile Formulation Development Models, Specifications and Application
Table 60. Piramal Pharma Solutions Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 61. Piramal Pharma Solutions Recent Developments
Table 62. Ardena Company Information, Head Office, Market Area and Industry Position
Table 63. Ardena Company Profile and Main Business
Table 64. Ardena Sterile Formulation Development Models, Specifications and Application
Table 65. Ardena Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 66. Ardena Recent Developments
Table 67. Curida Company Information, Head Office, Market Area and Industry Position
Table 68. Curida Company Profile and Main Business
Table 69. Curida Sterile Formulation Development Models, Specifications and Application
Table 70. Curida Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 71. Curida Recent Developments
Table 72. Curia Global Company Information, Head Office, Market Area and Industry Position
Table 73. Curia Global Company Profile and Main Business
Table 74. Curia Global Sterile Formulation Development Models, Specifications and Application
Table 75. Curia Global Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 76. Curia Global Recent Developments
Table 77. Carbogen Amcis Company Information, Head Office, Market Area and Industry Position
Table 78. Carbogen Amcis Company Profile and Main Business
Table 79. Carbogen Amcis Sterile Formulation Development Models, Specifications and Application
Table 80. Carbogen Amcis Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 81. Carbogen Amcis Recent Developments
Table 82. Woodstock Sterile Solutions Company Information, Head Office, Market Area and Industry Position
Table 83. Woodstock Sterile Solutions Company Profile and Main Business
Table 84. Woodstock Sterile Solutions Sterile Formulation Development Models, Specifications and Application
Table 85. Woodstock Sterile Solutions Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 86. Woodstock Sterile Solutions Recent Developments
Table 87. Cambrex Company Information, Head Office, Market Area and Industry Position
Table 88. Cambrex Company Profile and Main Business
Table 89. Cambrex Sterile Formulation Development Models, Specifications and Application
Table 90. Cambrex Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 91. Cambrex Recent Developments
Table 92. Aenova Group Company Information, Head Office, Market Area and Industry Position
Table 93. Aenova Group Company Profile and Main Business
Table 94. Aenova Group Sterile Formulation Development Models, Specifications and Application
Table 95. Aenova Group Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 96. Aenova Group Recent Developments
Table 97. Lonza Company Information, Head Office, Market Area and Industry Position
Table 98. Lonza Company Profile and Main Business
Table 99. Lonza Sterile Formulation Development Models, Specifications and Application
Table 100. Lonza Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 101. Lonza Recent Developments
Table 102. Catalent Company Information, Head Office, Market Area and Industry Position
Table 103. Catalent Company Profile and Main Business
Table 104. Catalent Sterile Formulation Development Models, Specifications and Application
Table 105. Catalent Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 106. Catalent Recent Developments
Table 107. PPD Company Information, Head Office, Market Area and Industry Position
Table 108. PPD Company Profile and Main Business
Table 109. PPD Sterile Formulation Development Models, Specifications and Application
Table 110. PPD Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 111. PPD Recent Developments
Table 112. Althea Company Information, Head Office, Market Area and Industry Position
Table 113. Althea Company Profile and Main Business
Table 114. Althea Sterile Formulation Development Models, Specifications and Application
Table 115. Althea Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 116. Althea Recent Developments
Table 117. Baxter Company Information, Head Office, Market Area and Industry Position
Table 118. Baxter Company Profile and Main Business
Table 119. Baxter Sterile Formulation Development Models, Specifications and Application
Table 120. Baxter Sterile Formulation Development Revenue and Gross Margin, 2018-2023
Table 121. Baxter Recent Developments
List of Figure
Figure 1. Sterile Formulation Development Picture
Figure 2. Global Sterile Formulation Development Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Sterile Formulation Development Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Sterile Formulation Development Market Share of Global
Figure 5. Global Sterile Formulation Development Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Sterile Formulation Development Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Sterile Formulation Development Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Sterile Formulation Development Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Sterile Formulation Development Industry Chain
Figure 10. Liquid Dosage Form
Figure 11. Lyophilized Dosage Form
Figure 12. Frozen Dosage Form
Figure 13. Others
Figure 14. By Type, Global Sterile Formulation Development Revenue, 2018-2029, US$ Million
Figure 15. By Type, Global Sterile Formulation Development Revenue Market Share, 2018-2029
Figure 16. Preclinical
Figure 17. Clinical
Figure 18. Commercial
Figure 19. By Application, Global Sterile Formulation Development Revenue, 2018-2029, US$ Million
Figure 20. By Application, Global Sterile Formulation Development Revenue Market Share, 2018-2029
Figure 21. By Region, Global Sterile Formulation Development Revenue Market Share, 2018-2029
Figure 22. North America Sterile Formulation Development Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Sterile Formulation Development Revenue Market Share, 2018-2023
Figure 24. Europe Sterile Formulation Development Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Sterile Formulation Development Revenue Market Share, 2018-2023
Figure 26. Asia Pacific Sterile Formulation Development Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Sterile Formulation Development Revenue Market Share, 2018-2023
Figure 28. South America Sterile Formulation Development Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Sterile Formulation Development Revenue Market Share, 2018-2023
Figure 30. Middle East & Africa Sterile Formulation Development Revenue & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Sterile Formulation Development Revenue, 2018-2029, (US$ Million)
Figure 32. By Company, U.S. Sterile Formulation Development Market Share, 2018-2023
Figure 33. By Type, U.S. Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 34. By Application, U.S. Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 35. Europe Sterile Formulation Development Revenue, 2018-2029, (US$ Million)
Figure 36. By Company, Europe Sterile Formulation Development Market Share, 2018-2023
Figure 37. By Type, Europe Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 38. By Application, Europe Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 39. China Sterile Formulation Development Revenue, 2018-2029, (US$ Million)
Figure 40. By Company, China Sterile Formulation Development Market Share, 2018-2023
Figure 41. By Type, China Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 42. By Application, China Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 43. Japan Sterile Formulation Development Revenue, 2018-2029, (US$ Million)
Figure 44. By Company, Japan Sterile Formulation Development Market Share, 2018-2023
Figure 45. By Type, Japan Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 46. By Application, Japan Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 47. South Korea Sterile Formulation Development Revenue, 2018-2029, (US$ Million)
Figure 48. By Company, South Korea Sterile Formulation Development Market Share, 2018-2023
Figure 49. By Type, South Korea Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 50. By Application, South Korea Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 51. Southeast Asia Sterile Formulation Development Revenue, 2018-2029, (US$ Million)
Figure 52. By Company, Southeast Asia Sterile Formulation Development Market Share, 2018-2023
Figure 53. By Type, Southeast Asia Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 54. By Application, Southeast Asia Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 55. India Sterile Formulation Development Revenue, 2018-2029, (US$ Million)
Figure 56. By Company, India Sterile Formulation Development Market Share, 2018-2023
Figure 57. By Type, India Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 58. By Application, India Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 59. Middle East & Asia Sterile Formulation Development Revenue, 2018-2029, (US$ Million)
Figure 60. By Company, Middle East & Asia Sterile Formulation Development Market Share, 2018-2023
Figure 61. By Type, Middle East & Asia Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 62. By Application, Middle East & Asia Sterile Formulation Development Revenue Market Share, 2022 VS 2029
Figure 63. Research Methodology
Figure 64. Breakdown of Primary Interviews
Figure 65. Bottom-up Approaches
Figure 66. Top-down Approaches
Research Methodology:
Sterile Formulation Development Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|